Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services. The company focuses on the development, production, and commercialization of mAb (monoclonal antibody) biosimilar drugs, bio-betters, and mAbs. Its products in development cover a variety of therapeutic areas including oncology and autoimmune diseases.